Adjusted EPS Growth

CVS Health outlined a growth plan that leverages its Aetna, Caremark, Pharmacy and Health‑Care Delivery businesses to deliver best‑in‑class execution, transform consumer experience and become the partner of choice. The company revised its full‑year 2025 financial guidance—revenues ≥ $400 bn, adjusted EPS $6.60‑$6.70—and provided initial 2026 targets, aiming for a mid‑teens adjusted EPS compound annual growth rate through 2028. CVS also launched an AI‑native “Engagement as a Service” platform to unify and simplify health‑care interactions across its ecosystem.